Skip to content

A Comparative Study to Establish Safe Use Methods and Verify the Effects of Hypoxic Chambers

A Prospective, Single-Blind, Interventional Comparative Trial Aiming to Establish Safety Standards for Hypoxic Chamber Operation - Randomized Controlled Trial of Hypoxic Chambers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058917
Enrollment
30
Registered
2025-09-01
Start date
2025-10-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults will be enrolled.

Interventions

Participants will stay in a hypoxic chamber for 1 hour per day, 5 days per week, for 3 weeks. Participants will stay in a hypoxic chamber for 1 hour per day, 5 days per week, for 3 weeks.

Sponsors

Tohoku University
Lead Sponsor
Regenesom Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy individuals without a history of cardiovascular, internal medicine, or respiratory diseases 2. Aged 20 years or older and 65 years or younger at the time of enrollment 3. Not on any regular medication 4. Able to provide written informed consent for study participation

Exclusion criteria

Exclusion criteria: Participants meeting the following conditions will be excluded due to anticipated vulnerability or hypersensitivity to hypoxic exposure: 1. History of cardiovascular or respiratory disease, or currently under treatment for such conditions 2. Current smoking habit 3. History of an acute internal medicine illness (e.g., cold, bronchitis, or other infection) requiring medical consultation within the past two weeks Participants meeting the following conditions will be excluded as they may affect the evaluation of effectiveness: 1. Currently under treatment for diabetes mellitus or hypertension 2. Regular use of medication 3. Claustrophobia 4. Metal allergy

Design outcomes

Primary

MeasureTime frame
Circadian blood glucose variability will be assessed during a three-week intervention consisting of hypoxic exposure for 1 hour per day, 5 days per week.

Secondary

MeasureTime frame
Changes in blood oxygen saturation and blood pressure will be examined during a three-week intervention consisting of hypoxic exposure for 1 hour per day, 5 days per week.

Countries

Japan

Contacts

Public ContactTaku Nakai

Tohoku University Graduate School of Medicine Division of Oxygen Biology

taku.nakai.e7@tohoku.ac.jp0227178206

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026